Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '25 Aug 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	718,467	475,318	-	-	-	-
Enterprise Value	742,330	511,861	-	-	-	-
Last Close Price	20250.00	13430.00	-	-	-	-
PE Ratio	40.54	28.71	-	-	-	-
PS Ratio	3.17	2.13	-	-	-	-
PB Ratio	3.05	2.04	-	-	-	-
P/TBV Ratio	3.08	2.06	-	-	-	-
P/FCF Ratio	81.76	487.04	-	-	-	-
P/OCF Ratio	18.54	15.15	-	-	-	-
EV/Sales Ratio	3.28	2.29	-	-	-	-
EV/EBITDA Ratio	20.57	14.79	-	-	-	-
EV/EBIT Ratio	32.46	23.75	-	-	-	-
EV/FCF Ratio	84.47	524.48	-	-	-	-
Debt / Equity Ratio	0.27	0.29	0.26	0.27	0.20	0.11
Debt / EBITDA Ratio	1.79	1.94	1.72	2.99	2.12	1.31
Debt / FCF Ratio	7.33	68.84	15.93	-	-	2.24
Asset Turnover	0.70	0.77	0.78	0.65	0.59	-
Inventory Turnover	9.38	8.34	8.04	8.57	7.80	-
Quick Ratio	1.32	1.25	0.56	0.35	1.11	2.66
Current Ratio	1.82	1.80	1.31	0.90	1.84	3.49
Return on Equity (ROE)	7.83%	8.07%	5.87%	2.61%	2.79%	-
Return on Assets (ROA)	4.43%	4.67%	3.74%	1.05%	1.89%	-
Return on Capital (ROIC)	4.81%	5.14%	4.15%	1.14%	2.00%	-
Return on Capital Employed (ROCE)	8.00%	7.50%	6.70%	1.90%	3.20%	2.80%
Earnings Yield	2.47%	3.48%	-	-	-	-
FCF Yield	1.22%	0.21%	-	-	-	-
Dividend Yield	0.49%	0.74%	-	-	-	-
Payout Ratio	19.91%	-	-	85.93%	186.23%	954.00%
Buyback Yield / Dilution	1.64%	-18.30%	-300.39%	-	-	-
Total Shareholder Return	2.13%	-17.55%	-300.39%	-	-	-

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.